2.3.3.17	A290G	the strain harbouring the MAM1 variant produces more thrice-elongated methionine than the native MAM1	756230	
2.3.3.17	A290S	unchanged composition of chain-elongated amino acids. The strain harbouring the MAM1 variant produces more thrice-elongated methionine than the native MAM1	756230	
2.3.3.17	A290T	in the strain harbouring the MAM1 variant, SSU3 protein level is higher than in the strain harbouring wild-type MAM1. No chain-elongated amino acid products are found	756230	
2.3.3.17	A290T	the strain harbouring the MAM1 variant does not produce any of the chain-elongated amino acid products	756230	
2.3.3.17	G259A	in the strain harbouring the MAM1 variant, SSU3 protein level is higher than in the strain harbouring wild-type MAM1. No chain-elongated amino acid products are found	756230	
2.3.3.17	G259A	the strain harbouring the MAM1 variant does not produce amino acids elongated more than twice	756230	
2.3.3.17	G259A	the strain harbouring the MAM1 variant does not produce any of the chain-elongated amino acid products	756230	
2.3.3.17	T257C	the strain harbouring the MAM1 variant produces more thrice-elongated methionine than the native MAM1	756230	
2.3.3.17	T257D	in the strain harbouring the MAM1 variant, SSU3 protein level is higher than in the strain harbouring wild-type MAM1. The strain harbouring the MAM1 variant produces more thrice-elongated methionine than the native MAM1	756230	
2.3.3.17	T257G	the strain harbouring the MAM1 variant does not produce amino acids elongated more than twice	756230